Antibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalAntineoplastic Combined Chemotherapy Protocols
Dr. Robert Michael Eisner, DO
NPI1841372299PAC ID6800997313
- Medicare services, 2024
- 2,111
- Medicare patients, 2024
- 468
- Part D claims, 2024
- 1,396
- Publications
- 2
- Clinical trials
- 10
- Practice address
- 2650 Ridge Ave, Evanston, IL 60201
- Practice phone
- Call (847) 570-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Eisner's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Robert Michael Eisner is a hematologist and oncologist in Evanston, Illinois
Dr. Eisner practices at Evanston Hospital in Evanston, Illinois, part of Endeavor Health.
Dr. Eisner's NPI, 1841372299, was assigned on October 19, 2006. Dr. Eisner graduated from Arizona College of Osteopathic Medicine Mid Western University in 2000. Dr. Eisner holds Illinois license 036-107525.
NPI and contact details
- NPI
- 1841372299NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6800997313
- NPI enumeration date
- October 19, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (847) 570-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Robert Michael Eisner practices at Evanston Hospital in Evanston, Illinois
Dr. Eisner's primary practice is Evanston Hospital, at 2650 Ridge Ave, Evanston, IL 60201 in Cook County. The practice phone is (847) 570-2000.
- Evanston Hospital2650 Ridge Ave, Evanston, IL 60201 · Cook CountyPhone(847) 570-2000
Source: Dmand AI Affiliation Data
Dr. Robert Michael Eisner is affiliated with 4 sites of care and 2 medical groups
Dr. Eisner's primary practice is Evanston Hospital in Evanston, Illinois, part of Endeavor Health. Dr. Eisner is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Eisner to 2 more hospitals and 1 medical group, each named with a free account.
Northwestern Medicine Central DuPage HospitalEndeavor Health Medical Group2 hospitalsNames with a free account1 medical groupName with a free account
See all 6 affiliations for Dr. EisnerSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Robert Michael Eisner's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eisner practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Evanston Hospital | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Eisner practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Endeavor Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Robert Michael Eisner is one of 563 hematologists and oncologists in Illinois
Hematology and oncology is Dr. Eisner's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Eisner is licensed in Illinois.
Specialties and state licenses
- Hematology and oncology, IllinoisPrimary
Hematologists and oncologists near Dr. Eisner
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
563hematologists and oncologists in Illinois26hematologists and oncologists in Evanston22hematologists and oncologists at Evanston Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Robert Michael Eisner billed Medicare for 2,111 services in 2024
CMS data shows 2,111 Medicare services from Dr. Eisner across 9 procedure codes in 2024, for 468 Medicare patients. Medicare paid $187,293 for them.
Medicare services, 20242,111
Medicare patients468
Paid by Medicare$187,293
Procedure codes9
Dr. Eisner's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,5672024: 1,39211%
- Other services
- 2023: 02024: 719
- Surgery
- 2023: 112024: 0100%
Where Dr. Eisner's Medicare services took place, 2024
- In an office2,01495%
- In a facility975%
Dr. Eisner compared with the Illinois median for hematologists and oncologists, 2024
- Dr. Eisner
- Illinois median
- Medicare services
- 2,111vs 1,056100% above
- Medicare patients
- 468vs 28266% above
- Part D claims
- 1,190vs 3283.6 times
Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Eisner's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Eisner?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Eisner and other hematologists and oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Robert Michael Eisner treated 468 Medicare patients in 2024, average age 76
CMS counts 468 Medicare patients who saw Dr. Eisner in 2024. The largest group is 75 to 84, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Eisner's median patient age at 61, with 59% women.
Medicare patients, 2024468
Average age76
Average risk score2.35
Also on Medicaid8%
Dr. Eisner's Medicare patients by age, 2024
Dr. Eisner's Medicare patients by sex, 2024
- Women23751%
- Men23149%
Chronic conditions among Dr. Eisner's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis50%
- Diabetes32%
- Ischemic heart disease32%
- Chronic kidney disease31%
- Anxiety26%
- Mood disorders26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Eisner's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 61
Patient panel by sex, all payers
- Women59%
- Men40%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Robert Michael Eisner wrote 1,396 Medicare Part D claims in 2024
In 2024, Dr. Eisner wrote 1,396 Medicare Part D claims for 205 patients. 67% of them were for generic drugs. CMS names the drug for 1,190 of them, across 31 drugs with 11 or more claims each, at $5,335,987 in total drug cost. In 2023, CMS named 1,043 claims across 29 drugs.
Part D claims, 20241,396
Drugs named by CMS31
Total drug cost$5.3M
Part D patients205
Dr. Eisner's Part D claims by kind of drug, 2024
- Generic934 claims67%
- Brand-name462 claims33%
Dr. Eisner's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Eisner's Part D claims, 2024
- Opioids3%36 of 1,396 claims
- Antibiotics9%131 of 1,396 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0432024: 1,19014%
Drugs named by CMS: 31 in 2024, 29 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Robert Michael Eisner scored 96 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Eisner for performance year 2024, reported through an alternative payment model (APM). Dr. Eisner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eisner as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Eisner's MIPS scores, performance year 2024
- 96of 100Final score
- 88.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Eisner by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Robert Michael Eisner has 2 publications on record
Dmand AI links 2 papers to Dr. Eisner. The most frequent topics are Hodgkin Disease. Dr. Eisner's most frequent co-authors are Gary L. Dillehay, MD, Leo I. Gordon, MD and Reem Md Karmali, MD.
Papers2
Topics Dr. Eisner writes about most
- Hodgkin Disease
Dr. Eisner's most frequent co-authors
- Gary L. Dillehay, MD2 shared papers
- Leo I. Gordon, MD2 shared papers
- Reem Md Karmali, MD2 shared papers
Recent publications by Dr. Eisner
B7-H1 AntigenHodgkin DiseaseProgrammed Cell Death 1 Receptor
See who Dr. Eisner researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Eisner works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Robert Michael Eisner has worked on 10 clinical trials
Dmand AI links Dr. Eisner to 10 clinical trials, 6 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Carcinoma, Renal Cell. National Cancer Institute (NCI) sponsors the most, 9.
Clinical trials with Dr. Eisner by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 2/3: 2 trials
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Eisner's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Carcinoma, Renal Cell
- Chondrosarcoma, Mesenchymal
- Hodgkin Disease
Investigators on the most trials with Dr. Eisner
- Lara Natasha Durna, MD5 shared trials
- Ashraf R. Aziz, MD4 shared trials
- Craig Stephen Boddy, MD4 shared trials
Recent clinical trials with Dr. Eisner
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas (opens in a new tab)
Active, not recruitingPhase 2/3
Lymphoma, Large B-Cell, DiffuseLymphoma, B-CellVenetoclaxCyclophosphamideDoxorubicin Hydrochloride
A Multicenter Phase II Trial of Paclitaxel With and Without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects With Angiosarcoma (opens in a new tab)
Active, not recruitingPhase 2
NivolumabPaclitaxelCabozantinib S-malate
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabDacarbazine
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellVenetoclaxIbrutinibObinutuzumab
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellIbrutinibObinutuzumabVenetoclax
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Robert Michael Eisner received $12,165 in industry payments from 2016 to 2025
CMS Open Payments shows 16 general payments to Dr. Eisner from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Kite Pharma, Inc. paid the most, $6,424.
General payments to Dr. Eisner by program year, 2016 to 2025
General payments to Dr. Eisner by kind, 2016 to 2025
$12.2Kin total
- Consulting fees$10,07083%
- Travel and lodging$1,81015%
- Food and beverage$2692%
- Education$160%
Companies that paid Dr. Eisner the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Robert Michael Eisner graduated from Arizona College of Osteopathic Medicine Mid Western University
Dr. Eisner graduated from Arizona College of Osteopathic Medicine Mid Western University in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Robert Michael Eisner's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Robert Michael Eisner
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Robert Michael Eisner's NPI number?
Dr. Robert Michael Eisner's NPI number is 1841372299. It was assigned on October 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Robert Michael Eisner?
Dr. Robert Michael Eisner is a hematologist and oncologist in Evanston, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Robert Michael Eisner practice?
Dr. Eisner practices at 2650 Ridge Ave, Evanston, IL 60201. Dr. Eisner's primary practice is Evanston Hospital in Evanston, Illinois, part of Endeavor Health. Dmand AI also links Dr. Eisner to 2 hospitals and 1 medical group.
What is Dr. Robert Michael Eisner's office phone number?
The practice phone on file for Dr. Eisner is (847) 570-2000.
What is Dr. Robert Michael Eisner's medical license number?
Dr. Eisner holds Illinois license 036-107525.
Which hospitals is Dr. Robert Michael Eisner affiliated with?
Dr. Eisner practices at Evanston Hospital in Evanston, Illinois. Dr. Eisner is also affiliated with Northwestern Medicine Central DuPage Hospital. Dmand AI links Dr. Eisner to 2 more hospitals.
What medical group is Dr. Robert Michael Eisner part of?
Dr. Eisner is linked to Endeavor Health Medical Group. Dmand AI links Dr. Eisner to 1 more medical group.
Does Dr. Robert Michael Eisner accept Medicare?
Yes. CMS data shows Dr. Eisner billed Medicare for 2,111 services in 2024, and Dr. Eisner accepts Medicare assignment.
Does Dr. Robert Michael Eisner offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Eisner as offering telehealth services.
What is Dr. Robert Michael Eisner's MIPS score?
Dr. Eisner's MIPS final score for performance year 2024 is 96 out of 100, reported through an alternative payment model (APM).
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Robert Michael Eisner see?
CMS counts 468 Medicare patients who saw Dr. Eisner in 2024, with an average age of 76.
What services does Dr. Robert Michael Eisner bill to Medicare?
In 2024, Dr. Eisner's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Robert Michael Eisner go to medical school?
Dr. Eisner graduated from Arizona College of Osteopathic Medicine Mid Western University in 2000.
What drugs does Dr. Robert Michael Eisner prescribe most?
In 2024 Medicare Part D data, Dr. Eisner's most prescribed drugs by claims were Acyclovir, Revlimid and Prednisone.
Has Dr. Robert Michael Eisner received payments from drug or device companies?
CMS Open Payments shows $12,165 in general payments to Dr. Eisner from 6 companies from 2016 to 2025. The largest total came from Kite Pharma, Inc.
How long has Dr. Robert Michael Eisner been practicing?
Dr. Eisner graduated from medical school in 2000, 26 years ago.
Does Dr. Robert Michael Eisner do research?
Dmand AI links 2 publications to Dr. Eisner. Dr. Eisner has worked on 10 clinical trials.
Who does Dr. Robert Michael Eisner publish with?
Dr. Eisner's most frequent co-authors are Gary L. Dillehay, MD (2 shared papers), Leo I. Gordon, MD (2 shared papers) and Reem Md Karmali, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card